The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Viewpoint: IARC’s defenders ignore cancer agency’s flawed research, conflicts of interest

| | August 21, 2018

I woke up …. to find an article by Neil Pearce, a professor at the London School of Hygiene and Tropical Medicine, entitled “Independent, rigorous, vilified – why attacks on the International Agency for Research on Cancer are unfair.”

The IARC Working Group which reviewed [the herbicide] glyphosate distorted the findings of animal studies, ignoring the consistent absence of increased tumors in rats and mice exposed to increasing does of the chemical …. IARC has [also] ignored rigorous re-analyses of the animal data exposing these improprieties.

…. Pearce – conveniently – ignores the fact that IARC’s assessment of glyphosate stands in sharp contrast to the judgment of virtually every other health and regulatory agency. These have found glyphosate to be safe …. To have pointed out this glaring disagreement with other international and national agencies might have undermined Pearce’s desire to attribute any criticism of IARC to pro-industry vested interests.

Related article:  EU health commissioner: Anti-vaccine, glyphosate 'conspiracy theories' threaten Europe with 'new middle ages'

[A] key figure in the Agency’s glyphosate assessment has his own glaring conflict-of-interest. In 2014 an American scientist Chris Portier initially proposed that the Agency review glyphosate. He then participated on the glyphosate panel as an outside expert. Then, within weeks of the publication of IARC’s glyphosate judgment in March, 2015, Portier became a litigation consultant for two law firms that were bringing lawsuits against Monsanto ….

Read full, original article: With Defenders Like These, The International Agency for Research on Cancer Hardly Needs Enemies

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend